The new sensor expands AcuMEMS’s product line directly into the area of cataract surgery and is designed for simple implantation during IOL surgery through an un-enlarged phaco/IOL incision, similar to the capsular tension ring procedure.

Glaucoma Center of San Francisco executive director and ophthalmologist Andrew Iwach said that IOP is still the best predictor of glaucoma progression we have, as well as the only proven treatable parameter and could use more accurate IOP data, which should help to protect patient’s vision.

“Implantation of this new technology during cataract surgery offers an ideal opportunity since there should be minimal additional surgical risk yet tremendous potential benefit,” Iwach said.